Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Braud

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Seminars in Oncology|June 1, 1993
Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neckF de Braud, M al-Sarraf
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?S Pusceddu, R Buzzoni, F De Braud
Critical Reviews in Oncology/Hematology|June 20, 1998
Gastric cancerR A Audisio, F de Braud, J Wils
Critical Reviews in Oncology/Hematology|May 8, 1998
Colorectal cancerR A Audisio, F de Braud, J Wils
Oncology|September 1, 1994
Home treatment with interleukin 2 and beta-interferon in patients with colorectal cancer and hepatocellular carcinomaF de Braud, M Colleoni, F Noli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2012
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306F Pietrantonio, M C Garassino, V Torri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?N Fazio, F de Braud, G Delle Fave, et al.
Tumori|August 31, 1992
Adjuvant chemotherapy for cancer of gastrointestinal tract: a critical reviewF de Braud, E Bajetta, M Di Bartolomeo, et al.
Haematologica|July 1, 1988
Acute leukemia with the (4;11) chromosome translocation following treatment for Hodgkin's disease: a case studyA Orazi, G Sozzi, G Cattoretti, et al.
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Seminars in Oncology|June 1, 1993
Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neckF de Braud, M al-Sarraf
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?S Pusceddu, R Buzzoni, F De Braud
Critical Reviews in Oncology/Hematology|June 20, 1998
Gastric cancerR A Audisio, F de Braud, J Wils
Critical Reviews in Oncology/Hematology|May 8, 1998
Colorectal cancerR A Audisio, F de Braud, J Wils
Oncology|September 1, 1994
Home treatment with interleukin 2 and beta-interferon in patients with colorectal cancer and hepatocellular carcinomaF de Braud, M Colleoni, F Noli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2012
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306F Pietrantonio, M C Garassino, V Torri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?N Fazio, F de Braud, G Delle Fave, et al.
Tumori|August 31, 1992
Adjuvant chemotherapy for cancer of gastrointestinal tract: a critical reviewF de Braud, E Bajetta, M Di Bartolomeo, et al.
Haematologica|July 1, 1988
Acute leukemia with the (4;11) chromosome translocation following treatment for Hodgkin's disease: a case studyA Orazi, G Sozzi, G Cattoretti, et al.
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
Pageof 14